A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

NCT01210768 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Epirubicin+Cyclophosphamide
DRUG: liposomal-doxorubicin+Cyclophosphamide

Sponsor

TTY Biopharm